Skip to Content
Merck
  • Notch 1 is a valuable therapeutic target against cell survival and proliferation in clear cell renal cell carcinoma.

Notch 1 is a valuable therapeutic target against cell survival and proliferation in clear cell renal cell carcinoma.

Oncology letters (2017-09-21)
Zhiming Zhuang, Jiangui Lin, Yiqun Huang, Tianqi Lin, Zhouda Zheng, Xudong Ma
ABSTRACT

Notch 1 is a key component of the Notch pathway, which performs a crucial role in clear cell renal cell carcinoma (CCRCC) development. The present study aimed to investigate whether Notch 1 could serve as a potential target for CCRCC treatment. Firstly, an association analysis was performed using 52 CCRCC cases and 30 normal controls. The results indicated that Notch 1 protein expression in renal tissues was closely associated with the incidence of CCRCC. In addition, higher Notch 1 expression in CCRCC tissues was positively associated with higher tumor-node-metastasis stage and Fuhrman grade, in addition to larger tumor size. Subsequently, an

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-NOTCH1 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution